Brief: Nightingale Health H1 EBITDA Loss Widens To EUR 5.5 Mln

Nightingale Health Oyj

23/03/2023 09:58

March 23 (Reuters) - Nightingale Health Oyj  HEALTH.HE :
    * HALF-YEAR REPORT 1 JULY 2022 - 31 DECEMBER 2022:
COMMERCIALIZATION PROGRESSING IN LINE WITH STRATEGY
    * H1 EBITDA WAS EUR -5.46 (-4.13) MILLION
    * H1 REVENUE WAS EUR 2.24 (1.27) MILLION
    * H1 OPERATING LOSS WAS EUR -8.67 (-5.91) MILLION

Source text for Eikon:  ID:nWkr7S1p3d 
Further company coverage:  HEALTH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))